These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21063038)

  • 1. Adiponectin levels and its role in insulin resistance among adult women with metabolic syndrome.
    Soebijanto N; Waspadji S
    Acta Med Indones; 2010 Oct; 42(4):187-91. PubMed ID: 21063038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoadiponectinemia: a risk factor for metabolic syndrome.
    Renaldi O; Pramono B; Sinorita H; Purnomo LB; Asdie RH; Asdie AH
    Acta Med Indones; 2009 Jan; 41(1):20-4. PubMed ID: 19258676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
    Seino Y; Hirose H; Saito I; Itoh H
    Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome.
    Salas-Salvadó J; Granada M; Bulló M; Corominas A; Casas P; Foz M
    Metabolism; 2007 Nov; 56(11):1486-92. PubMed ID: 17950098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report: a serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population.
    Koh SB; Park JK; Yoon JH; Chang SJ; Oh SS; Kim JY; Ryu SY; Kim KS; Lee TY; You JS
    Metabolism; 2010 Mar; 59(3):333-7. PubMed ID: 19796779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist circumference and serum adiponectin levels in obese and non-obese postmenopausal women.
    Milewicz A; Jedrzejuk D; Dunajska K; Lwow F
    Maturitas; 2010 Mar; 65(3):272-5. PubMed ID: 20004538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.
    Yun JE; Sull JW; Lee HY; Park E; Kim S; Jo J; Lee SJ; Kim SY; Choi YJ; Jee SH; Huh KB
    Diabetes Metab Res Rev; 2009 Mar; 25(3):259-65. PubMed ID: 19214966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
    Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women.
    Esmaillzadeh A; Mirmiran P; Moeini SH; Azizi F
    Int J Cardiol; 2006 Apr; 108(3):338-45. PubMed ID: 15963581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
    Grigorescu M; Radu C; Crişan D; Grigorescu MD; Serban A; Neculoiu D; Rusu M; Acalovschi M
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):147-54. PubMed ID: 18568135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference.
    Onat A; Hergenç G; Yüksel H; Can G; Ayhan E; Kaya Z; Dursunoğlu D
    Clin Nutr; 2009 Feb; 28(1):46-51. PubMed ID: 19010573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.